ETR:SBS - Stratec Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started €65.00 +1.40 (+2.20 %) (As of 05/20/2019 04:00 PM ET)Previous Close€63.60Today's Range€63.30 - €65.5052-Week Range€43.55 - €77.10Volume4,172 shsAverage Volume6,253 shsMarket Capitalization$777.17 millionP/E Ratio87.60Dividend Yield1.31%BetaN/A ProfileAnalyst RatingsChartHeadlinesOptions Chain Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Stratec SE designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany and internationally. The company operates through three segments: Instrumentation, Diatron, and Consumables. The Instrumentation segment designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications. The Consumables segment develops and sells scientific materials, such as nucleic acid purification; and designs and manufactures smart consumables in the fields of diagnostics, life sciences, and medical technology. Stratec SE also develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany. Receive SBS News and Ratings via Email Sign-up to receive the latest news and ratings for SBS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange ETR Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolETR:SBS Previous Symbol CUSIPN/A CIKN/A Webwww.stratec.com Phone+49-7082-79160Debt Debt-to-Equity Ratio45.69 Current Ratio3.26 Quick Ratio1.69Price-To-Earnings Trailing P/E Ratio87.60 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$187.82 million Price / Sales4.14 Cash Flow€2.10 per share Price / Cash Flow30.90 Book Value€12.72 per share Price / Book5.11Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees1,158 Outstanding Shares11,956,500Market Cap$777.17 million Next Earnings Date5/24/2019 (Estimated) OptionableOptionable Stratec (ETR:SBS) Frequently Asked Questions What is Stratec's stock symbol? Stratec trades on the ETR under the ticker symbol "SBS." When is Stratec's next earnings date? Stratec is scheduled to release their next quarterly earnings announcement on Friday, May 24th 2019. View Earnings Estimates for Stratec. What price target have analysts set for SBS? 3 Wall Street analysts have issued 12-month price objectives for Stratec's shares. Their predictions range from €55.00 to €81.00. On average, they anticipate Stratec's share price to reach €70.33 in the next year. This suggests a possible upside of 8.2% from the stock's current price. View Analyst Price Targets for Stratec. What is the consensus analysts' recommendation for Stratec? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stratec in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Stratec. Has Stratec been receiving favorable news coverage? Headlines about SBS stock have trended somewhat negative this week, InfoTrie reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Stratec earned a daily sentiment score of -1.0 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near term. Who are some of Stratec's key competitors? Some companies that are related to Stratec include ConvaTec Group (CTEC), Inspire Medical Systems (INSP), Draegerwerk AG & Co KGaA (DRW3), Avita Medical (AVH), Creo Medical Group (CREO), Medica Group (MGP), Hamilton Thorne (HTL), Titan Medical (TMD), Advanced Oncotherapy (AVO), Cyclopharm (CYC), Impedimed (IPD), Helius Medical Technologies (HSM), Kromek Group (KMK), REVA Medical (RVA) and Osprey Medical (OSP). What other stocks do shareholders of Stratec own? Based on aggregate information from My MarketBeat watchlists, some companies that other Stratec investors own include Payment Data Systems (PYDS), PetIQ (PETQ), Ollie's Bargain Outlet (OLLI), Masimo (MASI), HD Supply (HDS), Gogo (GOGO), Depomed (DEPO), Apptio (APTI), Align Technology (ALGN) and Marks and Spencer Group (MKS). Who are Stratec's key executives? Stratec's management team includes the folowing people: Mr. Marcus Wolfinger, Chairman of Board of Management & CEO (Age 52)Dr. Robert Siegle, Director of Fin. & HR and Member of Board of Management (Age 52)Dr. Claus Vielsack, Director of Product Devel. & Member of Board of Management (Age 52)Mr. Hermann Leistner, Founder & Advisor (Age 73)Sandra Eberle, Head of Investor Relations What is Stratec's stock price today? One share of SBS stock can currently be purchased for approximately €65.00. How big of a company is Stratec? Stratec has a market capitalization of $777.17 million and generates $187.82 million in revenue each year. Stratec employs 1,158 workers across the globe. What is Stratec's official website? The official website for Stratec is https://www.stratec.com/. How can I contact Stratec? Stratec's mailing address is Gewerbestr. 37, BIRKENFELD, 75217, Germany. The company can be reached via phone at +49-7082-79160. MarketBeat Community Rating for Stratec (ETR SBS)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 119 (Vote Outperform)Underperform Votes: 93 (Vote Underperform)Total Votes: 212MarketBeat's community ratings are surveys of what our community members think about Stratec and other stocks. Vote "Outperform" if you believe SBS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/20/2019 by MarketBeat.com StaffFeatured Article: Channel Trading Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.